Novo Nordisk still sees potential for GLP-1 drugs for Alzheimer’s, despite trial setback

Novo Nordisk says it still thinks GLP-1 drugs could be a promising treatment for Alzheimer’s, despite two disappointing trials last month.

Next-level Ozempic is coming — inside the new era of weight-loss drugs about to drop

And Big Pharma’s not done cashing in on the weight-loss boom. Drugmakers are readying a new wave of next-level GLP-1 treatments, with several promising candidates in the pipeline. These experimental ...